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Plant Secondary Metabolite Biosynthesis
Our research interests focus on the molecular design and synthesis of specific inhibitors of physiologically important 
enzymes (biocatalysts) for use as chemical probes to understand the reaction mechanisms, three-dimensional structures 
and physiological roles of the enzymes. The finely designed inhibitors are further elaborated to develop pharmaceuticals 
and agrochemicals. Our research includes: Design, synthesis and applications of transition-state analogue and 
mechanism-based inhibitors of the key enzymes in glutathione homeostasis, asparagine synthetase, and the development 
of intermediate analogue inhibitors of acyl-activating enzyme superfamily that plays pivotal roles in plant hormone and 
secondary metabolite biosynthesis.
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Design, Synthesis and Applications of Specific 
Inhibitors of g-Glutamyl Transpeptidase for 
Modulating Cellular Redox Status
Glutathione (GSH, γ-Glu-Cys-Gly) is an ubiquitous 
 tripeptide containing Cys found in many organisms. It 
plays central roles in the redox status of cells not only by 
detoxification of reactive oxygen species, but also by 
 regulating the transcription of specific genes such as 
phase II antioxidant enzymes. We are interested in regu-
lating the cellular GSH level by controlling the activities 
of its biosynthetic enzyme, γ-glutamylcysteine synthetase 
(GCS), and its metabolic enzyme, γ-glutamyl transpepti-
dase (GGT), by using specific inhibitors (Figure 1). GGT 
is a key enzyme in supplying the cells with Cys by cleav-
ing the γ-glutamyl bond of extracellular GSH, as well as 
in degrading GSH conjugates for detoxification. We de-
veloped a series of phosphonate-based inactivators of 
GGT and found that an inhibitor was highly efficient for 
human GGT. Interestingly, this inhibitor significantly in-
creased the biosynthesis of type I collagen and elastin of 
human skin fibroblasts and can be used, for example, as a 
novel antiaging cosmetic ingredient. The study on its 
mode of action and its application as a novel “cosmeceuti-
cal” are in progress.
Inhibitors Targeting Human Asparagine 
Synthetase for Cancer Chemotherapy
Human asparagine synthetase (hAS) catalyzes the ATP-
dependent synthesis of Asn from Asp using Gln as an 
 ammonia source. The inhibition of hAS is highly impor-
tant in enhancing and broadening the efficacy of asparagi-
nase chemotherapy of leukemia and cancer. We previously 
developed the first nano molar in vitro hAS inhibitor 1 
(Ki*=24 nM) and succeeded in suppression of proliferation 
of asparaginase-resistant cancer cell line, but at higher 
concentrations (100–1000 mM). The bioavailability of 1 
was increased by removing a caboxy group to eliminate net 
negative charge. Surprisingly, the new compound 2 inhibit-
ed hAS even stronger (Ki*=7.6 nM) than the original 1 
and not only suppressed cell proliferation in a dose-depen-
dent manner, but also induced cell death irrespective of 
the presence of asparaginase. This result suggests that 
hAS in itself is a novel target without the aid of asparaginase, 
which might open a new paradigm for anti-cancer chemo-
therapy.
Specific Inhibitors of Acyl-activating 
Enzymes for “Chemical Knockout”
Acyl-activating enzymes constitute a large enzyme 
 superfamily that contains a number of such important 
 enzymes as for fatty acid b-oxidation and biosynthesis of 
plant secondary metabolites. In light of their common 
mechanistic features involving acyl-adenylate intermediate, 
we designed and synthesized N-acyl adenosyl sulfamides 
as intermediate-analogue inhibitors to probe the physiologi-
cal impact of a key enzyme 4-coumaric acid:CoA ligase (4CL) 
on phenylpropanoid biosynthesis. The synthetic com-
pounds inhibited 4CL in vitro, and the substituents on 
benzene ring significantly affected their potency. Admin-
istration of the inhibitors to Arabidopsis caused decrease 
of the phenylpropanoids contents. This result implied that 
the inhibitors were up-taken by plants and inhibited 4CL 
in vivo. The inhibitors are promising tools for chemical 
biology of plants for controlling plant secondary metabo-
lites including the phenylpropene volatiles and lignin bio-
synthesis.
Figure 1. Biosynthesis, reaction, and metabolism of glutathione (GSH) 
in cell. The specific inhibitors of GCS and GGT are shown in red 
squares.
Figure 2. (Left) The structure of the original inhibitor 1 and newly 
synthesized inhibitor 2. (Right) X-Ray crystal structure of E. coli AS in 
complex with 1.
Figure 3. The outline of phenylpropanoid biosynthesis and the structure 
of intermediate analogue inhibitors.
